NOVADRUG LLC has a total of 26 patent applications. Its first patent ever was published in 2011. It filed its patents most often in Australia, Canada and China. Its main competitors in its focus markets pharmaceuticals and environmental technology are IRR INC, SIGMOID BIOTECHNOLOGIES LTD and FAULK PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 3 | |
#2 | Canada | 3 | |
#3 | China | 3 | |
#4 | EPO (European Patent Office) | 3 | |
#5 | WIPO (World Intellectual Property Organization) | 3 | |
#6 | Hong Kong | 2 | |
#7 | Israel | 2 | |
#8 | South Africa | 2 | |
#9 | EAPO (Eurasian Patent Organization) | 1 | |
#10 | India | 1 | |
#11 | Republic of Korea | 1 | |
#12 | New Zealand | 1 | |
#13 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Huberman Eliezer | 23 |
#2 | Huberman Eliezer E | 1 |
Publication | Filing date | Title |
---|---|---|
EA027810B1 | Heterocyclyl carboxamides for treating viral diseases | |
EP2747765A1 | Compositions and methods for treating viral diseases | |
NZ601661A | Compositions and methods for treating viral diseases |